EGFR and adenocarcinoma: The most prevalent history of disease included the incidence of adenocarcinoma (96.3%), 10 patients (37.0%) had relapse after surgery, and all the patients had exon 19 deletion or an L858R deletion in exon 21; these were the most common mutation types in EGFR.